MedTrace Logo

Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression

NCT00177528 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2008-10-09

No results posted yet for this study

Summary

This research study is to evaluate the safety and usefulness of venlafaxine-XR in the treatment of major depression in the elderly.

Conditions

Interventions

DRUG

venlafaxine-XR

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Ellen M Whyte, MD · University of Pittsburgh

  • Benoit H Mulsant, MD · University of Pittsburgh

  • Charles F. Reynolds III, MD · University of Pittsburgh

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2004-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00177528 on ClinicalTrials.gov